MART-1 (27–35) (human) is an antigenic peptide widely used in studies of melanocyte-associated protein recognition. Its sequence supports analyses of epitope presentation and MHC-binding motifs. Researchers apply it to probe conformational preferences contributing to T-cell recognition models. The peptide aids structural mapping of melanoma-associated epitopes.
CAT No: M2501
CAS No:156251-11-5
Synonyms/Alias:Melan A;156251-11-5;acetic acid;2-[[2-[[2-[[2-[[2-[[2-[[2-[2-(2-aminopropanoylamino)propanoylamino]acetyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoic acid;10: PN: WO2015162204 SEQID: 10 claimed sequence;MART-1 (27-35) (human) acetate salt;156251-11-5(free basis);DA-65258;FM110241;MART-1 (27-35) (human) trifluoroacetate salt;H-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH; H-AAGIGILTV-OH;
1. Emu oil in combination with other active ingredients for treating skin imperfections
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More